|
Contents
|
|
|
|
Astrocytomas
|
|
|
|
Mathieu NT, Genet D, Labrousse F, Bouillet P, Denes
SL, Martin J, Labourey JL, Venat L, Clavere P, Moreau JJ
Pre-irradiation chemotherapy for
newly diagnosed high grade astrocytoma
Anticancer Res. 2004 Mar-Apr;24(2C):1249-53.
|
|
|
Embryonal
Tumors
|
|
|
|
H.
Shirato, J. Ikeda, H. Aoyama, N. Ishii, T. Taguchi, T. Kato, M. Tada, Y.
Sawamura
Low-dose
craniospinal irradiation and ifosfamide, cisplatine, and etoposide for embryonal
tumors in central nervous system
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
430
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.
|
|
|
Glioblastoma
|
|
|
| |
Carmen
Balaña,
Antonio López-pousa,
Alfonso Berrocal, Ricardo Yaya-tur, Ana Herrero, Jose-luis García,
Javier Martín-broto,
Manuel Benavides, Miguel Cerdá-nicolás,
Rosa Ballester, Josep Balart, Jaume
Capellades
Phase
II study of temozolomide and cisplatin as primary treatment prior to
radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable
disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)
Journal
of Neuro-Oncology, 70(3):
359-370, December 2004. (Abstract+)
|
|
Balana C,
Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, Sarries C, Mendez P,
Sanchez JJ, Rosell R
O(6)-methyl-guanine-DNA
methyltransferase Methylation in Serum and Tumor DNA Predicts Response to
1,3-Bis(2-Chloroethyl)-1-Nitrosourea but not to Temozolamide Plus
Cisplatin in Glioblastoma Multiforme
Clin Cancer Res
2003 Apr;9(4):1461-8
|
|
Radiotherapy,
Cisplatin, Fotemustine, Temozolomide (Recurrent).
Radiotherapy, Temozolomide (First-diagnosis)
|
Balducci M, Chiesa S,
Diletto B, D'Agostino GR, Mangiola A, Manfrida S, Mantini G, Albanese A,
Fiorentino A, Frascino V, De Bari B, Micciche' F, De Rose F, Morganti AG,
Anile C, Valentini V.
Low-dose fractionated
radiotherapy and concomitant chemotherapy in glioblastoma multiforme with
poor prognosis: a feasibility study.
Neuro Oncol. 2011 Oct
12;. [Epub ahead of print]
.JPG) Abstract |
.gif) Related articles
|
|
Alba A.
Brandes, Umberto
Basso, Michele Reni, Francesca Vastola, Alicia
Tosoni, Giovanna Cavallo, Luciano Scopece,
Andres J. Ferreri, Maria G. Panucci, Silvio
Monfardini, Mario Ermani
First-Line Chemotherapy
With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma
Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di
Neuro-Oncologia
Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp.
1598-1604.
|
|
In
Sil Choi , Se
Hoon Lee, Tae-You Kim, Sun Ha Paek, Suzy Kim, Il Han Kim, Dae Seog Heo,Yung-Jue
Bang, Dong Gyu Kim, Hee-Won Jung, Noe Kyeong Kim
Phase
II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial
Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme
Journal
of Neuro-Oncology, 60
(2): 171-176, November 2002
|
|
C. F. Classen, M. Warmuth-Metz, K. Papke,
A. Trotter, J. E. A. Wolff, S. Wagner
Late
response to radiochemotherapy in pediatric glioblastoma: report on two
patients treated according to HIT-GBM protocols
Pediatr
Hematol Oncol. 2006
Dec;23(8):631-7. DOI: 10.1080/08880010600951088
|
|
Mario
Ermani, Alba A Brandes, Lara M Pasetto, Umberto Basso, Michele Reni,
Sergio Turazzi, Silvia Berlucchi, Paolo Iuzzolino, Giampietro Pinna, Renato
Scienza, Silvio Monfardini
First
line chemotherapy with cisplatin plus fractionated temozolomide (bid) in
recurrent glioblastoma (GBM)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
|
|
E.
Franceschi, L. Scopece, G. Cavallo, R. Degli Esposti, F. Spagnolli, S.
Rimondini, R. Conforti, E. Palmerini, S. Gori, L. Crino
Temozolomide
and cisplatin for the treatment of glioblastoma: A phase II study
39th ASCO Annual
Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 481
|
|
|
Han JH, Park CK, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo
DS, Kim IH, Jung HW.
Preradiation Chemotherapy with ACNU-CDDP in Patients with Newly Diagnosed
Glioblastoma: A Retrospective Analysis
Chemotherapy. 2009 Apr 22;55(3):145-154. [Epub ahead of print]
Abstract
|
|
|
Kim
IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM,
Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW.
Radiotherapy followed by adjuvant temozolomide with or without
neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a
prospective randomized controlled multicenter phase III trial.
J
Neurooncol. 2010 Nov 4. [Epub ahead of print]
Abstract |
.png)
Reprint |
Related articles
|
|
Sheleg
SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG,
Yurkshtovich TL, Bychkovsky PB, Belyaev SA
Local chemotherapy with cisplatin-depot for
glioblastoma multiforme
J Neurooncol 2002 Oct;60(1):53-9
|
|
|
E. Schuller, R. Seidl, C. Wandl, K. Dieckmann, I. Slavc
Prolonged
Second Response To Cisplatin, Etoposide, And Ifosfamide In A Child With A Recurrent
Brainstem Glioblastoma
Pediatric
Hematology and Oncology, Volume 18, Number 4/June 1, 2001,
253 - 258
Abstract
|
|
|
Silvani A, Gaviani P, Lamperti EA, Eoli M, Falcone C, Dimeco F, Milanesi IM,
Erbetta A, Boiardi A, Fariselli L, Salmaggi A
Cisplatinum
and BCNU chemotherapy in primary glioblastoma patients
J Neurooncol.
2009 Feb 11. [Epub ahead of print]
Abstract
|
|
|
Gliomas
|
|
|
|
W. O.
Arafat, D. Rein, D.
Buchsbaum, D. Curiel, Z. Zhu
Survivin as a novel radiation/CIS
platinum/tumor specific promoter for conditional oncolytic viral therapy
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1535
|
|
Marco Balzarotti, Emilio Ciusani, Chiara Calatozzolo, Danilo Croci,
Amerigo Boiardi, and Andrea Salmaggi
Effect of Association of Temozolomide With Other
Chemotherapic Agents on Cell Growth Inhibition in Glioma Cell Lines
Oncology Research, 2004, Volume 14, pp. 325-330.
|
|
Christine Billecke, Susan Finniss,
Laura Tahash, Cathie Miller, Tom Mikkelsen,
Nicholas P. Farrell and Oliver Bögler
Polynuclear platinum anticancer drugs are more potent than cisplatin and
induce cell cycle arrest in glioma
Neuro-oncol 2006 Jul 1; 8(3):215-226; Epub 2006 May 24
Abstract
|
|
Bourg
V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based
chemotherapy associated with valproate: increase of haematologic toxicity.
Ann Oncol 2001 Feb;12(2):217-9
Abstract |
Reprint |
Related articles
|
|
Maria
Gonzalez Cao, Javier Aristu, Marta Santisteban, Jose M Ordonez, Jose M
Aramendia, Ignacio Bilbao, Oscar Fernandez, Salvador Martin Algarra
Phase
II trial of BCNU, temozolamide (TMZ) plus intraarterial cisplatin (CDDP) in
unresectable or recurrent high grade glioma
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract
No.
2099
|
|
Antonio
Silvani, Marica Eoli, Andrea Salmaggi, Elena Lamperti, Elio
Maccagnano, Giovanni Broggi, Amerigo Boiardi
Phase
II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive
Malignant Glioma Patients
Journal of Neuro-Oncology, 66 (1-2): 203-208, January 2004
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Blumenthal DT, Rankin C, Eyre HJ, Livingston RB,
Spence AM, Stelzer KJ, Rushing EJ, Berger MS, Rivkin SE, Cohn AL, Petersdorf
SH.
External beam irradiation and the combination of cisplatin and carmustine
followed by carmustine alone for the treatment of high-grade glioma: a phase
2 Southwest Oncology Group trial
Cancer. 2008 Jun 2. [Epub
ahead of print]
Abstract
|
|
Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner
P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet
JC, Raquin MA, Kalifa C.
High-grade glioma in children under 5 years of age: A
chemotherapy only approach with the BBSFOP protocol.
Eur J Cancer.
2006 Sep 6; [Epub ahead of print]
Abstract
|
|
|
Zustovich
F, Lombardi G, Della Puppa A, Rotilio A, Scienza R, Pastorelli D
A phase II study of cisplatin and temozolomide in heavily pre-treated
patients with temozolomide-refractory high-grade malignant glioma
Anticancer Res. 2009 Oct;29(10):4275-9
Abstract
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Massimino
M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori
L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA,
Catania S, Sardi I, Giangaspero F
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood
progressive low-grade glioma
J
Neurooncol. 2010 Feb 12. [Epub ahead of print]
Abstract
| .png)
Full
Text |
Reprint
|
|
|
Medulloblastoma
|
|
|
|
Khoshyomn S, Manske GC, Lew SM, Wald SL, Penar PL
Synergistic
action of genistein and cisplatin on growth inhibition and cytotoxicity of human
medulloblastoma cells
Pediatr Neurosurg 2000 Sep;33(3):123-31
|
|
Mothaffar
F Rimawi, Suleiman
Massarweh, Vu Ho, Uday Popat, Garrett R Lynch
Adult
cerebellar medulloblastoma at Ben Taub General Hospital
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No. 2110
|
|
|
Paulino AC, Mazloom A, Teh BS, South M, Okcu MF,
Su J, Butler EB, Chintagumpala M
Local
control after craniospinal irradiation, intensity-modulated radiotherapy
boost, and chemotherapy in childhood medulloblastoma
Cancer. 2010 Sep
15. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Saito R, Kumabe T, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga
T.
Combination
chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma:
single-institute experience and differences in efficacy for subgroups of
medulloblastoma.
Childs
Nerv Syst. 2011 May 18. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Silvani A, Gaviani P, Lamperti E, Botturi A, Dimeco F, Franzini A, Ferroli
P, Fariselli L, Milanesi I, Erbetta A, Pollo B, Salmaggi A.
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and
etoposide: a single institutional experience.
J Neurooncol.
2011 Aug 27. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Metastatic
Tumors
|
|
|
|
|
Christos Christodoulou,
Dimitrios Bafaloukos, Helen Linardou,
Gerassimos Aravantinos, Aristotelis Bamias,
Maria Carina, George Klouvas and
Dimosthenis Skarlos
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with
brain metastases from solid tumors: a Hellenic Cooperative Oncology
Group (HeCOG) Phase II study
Journal
of Neuro-Oncology, 71(1):
61-65, January 2005. (Abstract+)
|
|
Nasopharyngeal
Carcinoma
|
|
|
G.
Brandon Gunn, Ruben D. Villa, Ross R. Sedler, Fred Hardwicke, Gianluigi
A. Fornari, Rufus J. Mark
Nasopharyngeal
Carcinoma Metastasis to the Pituitary Gland: A Case Report and Literature
Review
Journal of Neuro-Oncology, 68 (1): 87-90, May 2004. (Abstract+)
|
|
Lung Cancer
|
|
|
D. Y. Kim, K. W. Lee, T. Yun,
J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of
platinum-based chemotherapy after cranial irradiation in patients with brain
metastasis from non-small cell lung cancer
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004. (Abstract+)
|
|
|
Neuroblastoma
|
|
|
|
Elisabetta Donzelli, Maria
Carfì, Mariarosaria Miloso, Alberto Strada, Stefania Galbiati, Martine
Bayssas, Genevieve Griffon-Etienne, Guido Cavaletti, Maria Grazia
Petruccioli and Giovanni Tredici
Neurotoxicity of platinum
compounds: comparison of the effects of cisplatin and oxaliplatin on the
human neuroblastoma cell line SH-SY5Y
J Neurooncol. 2004 Mar-Apr;67(1-2):65-73. (Abstract+)
|
|
|
Tsuchida R, Das B, Yeger H, Koren G, Shibuya M,
Thorner PS, Baruchel S, Malkin D.
Cisplatin treatment increases survival and expansion of a highly
tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine
signaling
Oncogene. 2008 Jun 26;27(28):3923-34.
Epub 2008 Mar 10
Abstract
|
|
|
Non-Nervous
System T.
|
|
|
|
Kosty
MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris
JC, Mortimer J, Green MR
Cisplatin,
vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a
randomized placebo-controlled, double-blind phase III study of the Cancer and
Leukemia Group B
J Clin Oncol 1994 Jun;12(6):1113-20
|
|
Li D, Williams JI, Pietras RJ
Squalamine
and cisplatin block angiogenesis and growth of human ovarian cancer cells with
or without HER-2 gene overexpression
Oncogene 2002 Apr 25;21(18):2805-14
|
|
Scambia G, De Vincenzo R, Ranelletti
FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli
E,
Mancuso S
Antiproliferative
effect of silybin on gynaecological malignancies: synergism with
cisplatin and doxorubicin
Eur J Cancer. 1996
May;32A(5):877-82
|
|
|
Bokemeyer
C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H,
Lentzen H
Silibinin
protects against cisplatin-induced nephrotoxicity without compromising
cisplatin or ifosfamide anti-tumour activity
Br J Cancer. 1996 Dec;74(12):2036-41
|
|
Pace A, Savarese A, Picardo M,
Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B,
Cognetti F, Bove L
Neuroprotective
effect of vitamin e supplementation in patients treated with Cisplatin
chemotherapy
J Clin Oncol 2003 Mar 1;21(5):927-31
|
|
|
Oligoastrocytoma (Anapl.)
|
|
|
|
Boiardi A, Eoli M, Salmaggi A, Pollo
B, Milanesi I, Broggi G, Silvani A
Cisplatin and BCNU chemotherapy for
anaplastic oligoastrocytomas
J
Neurooncol 2000 Aug;49(1):71-5
|
|
|
Pediatric
Patients
|
|
|
|
Birgit
Geoerger, Gilles Vassal, Francois Doz, Marie A Raquin, Didier Frappaz,
Pascal Chastagner, Herve Rubie, Jean-Claude Gentet, John O'Quigley, Kamal
Djazouli, Geoffrey P Margison, Francois Pein
Dose-finding
study and O6-alkyltransferase depletion of cisplatin combined with
temozolomide in pediatric solid malignancies
ASCO Proceedings, 2002
Annual Meeting, Abstract No. 424
|
|
Maura Massimino,
Lorenza Gandola, Roberto Luksch, Filippo Spreafico, Daria Riva, Carlo
Solero, Felice Giangaspero, Franco Locatelli, Marta Podda, Fabio
Bozzi, Emanuele Pignoli, Paola Collini, Graziella Cefalo, Marco Zecca,
Michela Casanova, Andrea Ferrari, Monica Terenziani, Cristina Meazza,
Daniela Polastri, Davide Scaramuzza, Fernando Ravagnani, and Franca
Fossati-Bellani
Sequential chemotherapy, high-dose
thiotepa, circulating progenitor cell rescue, and radiotherapy for
childhood high-grade glioma
Neuro-Oncology, Volume
7, Number 1, Pages 41 -- 48, January 2005. (Abstract+)
|
|
